Curanex Pharmaceuticals (CURX)
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflam...
- Open
- 0.2330
- High
- 0.2820
- Low
- 0.2330
- Prev. Close
- 0.2220
- Volume
- 1.83M
- Turnover
- 475.41K
- Avg Price
- 0.2597
- Bid/Ask Ratio
- 0.00%
- Amplitude
- 22.07%
- 52wk High
- 9.1800
- Volume Ratio
- 20.93
- Turnover Ratio
- 20.01%
News
- TradingView · Aug 14 at 11:21 AM
Curanex Pharmaceuticals Inc Q2 2026: Net income $(3.29M), EPS $(0.12) — 10-Q Summary
- PUBT · Aug 14 at 11:16 AM
Curanex net loss widens to $3.29 million in Q2 FY26; no revenue
- benzinga_article · Jul 29 at 07:05 AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga_article · Jun 30 at 07:05 AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- PUBT · Jun 29 at 09:20 AM
Curanex shareholders back 1-for-10 to 1-for-50 reverse stock split to meet Nasdaq $1 bid rule
- PUBT · Jun 18 at 04:12 PM
Curanex Pharmaceuticals files draft information statement (Form PRE 14C)
